Publications by authors named "Beate Gertz"

Claim this Profile
M
Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap (XM17), Comparability with Gonal-f, and Performance/Consistency.
Rainer Winstel, Juergen Wieland, Beate Gertz, Arnd Mueller, Hermann Allgaier

Drugs R D· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.
Andreas Lammerich, Peter Bias, Beate Gertz

Int J Womens Health· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin theta: efficacy and safety of subcutaneous administration in anemic pre-dialysis patients in the maintenance phase in comparison to epoetin beta.
Beate Gertz, P Kes, A Essaian, P Bias, A Buchner

Curr Med Res Opin· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial.
Sergei A Tjulandin, Peter Bias, Reiner Elsässer, Beate Gertz, Erich Kohler

Arch Drug Inf· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial.
Sergei A Tjulandin, Peter Bias, Reiner Elsässer, Beate Gertz, Erich Kohler

Arch Drug Inf· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis